Status:
TERMINATED
Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Hemophilia
AIDS
Eligibility:
All Genders
4-100 years
Brief Summary
Background: Over 80% of the hemophiliac population who became infected with HIV prior to 1985 are also co-infected with HCV. Thus, hemophiliacs represent an important population for studies of the na...
Detailed Description
Background: Over 80% of the hemophiliac population who became infected with HIV prior to 1985 are also co-infected with HCV. Thus, hemophiliacs represent an important population for studies of the na...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- The current Study will involve analysis of existing samples (DNA, serum, cells, plasma) and data. The entire set of 333 subjects in the HGDS cohort will be analyzed.
- EXCLUSION CRITERIA:
- No subjects will be excluded from the HGDS cohort.
Exclusion
Key Trial Info
Start Date :
April 9 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 9 2020
Estimated Enrollment :
333 Patients enrolled
Trial Details
Trial ID
NCT00340548
Start Date
April 9 2002
End Date
January 9 2020
Last Update
January 13 2020
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego
La Jolla, California, United States, 92093-0603
2
Childrens Hospital, Los Angeles
Los Angeles, California, United States, 90054-0700
3
St. Vincent Hospital & Health Care Center
Indianapolis, Indiana, United States, 46260
4
University of Iowa
Iowa City, Iowa, United States, 52242-1101